Cancer Hallmarks, Biomarkers and Breast Cancer Molecular Subtypes - Wikidata - awgldk - TriplyDB

Cancer Hallmarks, Biomarkers and Breast Cancer Molecular Subtypes

Cancer Hallmarks, Biomarkers and Breast Cancer Molecular Subtypes

http://www.wikidata.org/entity/Q26743510

about

Oridonin inhibits breast cancer growth and metastasis through blocking the Notch signaling.Effect of macrophages on breast cancer cell proliferation, and on expression of hormone receptors, uPAR and HER-2 Phosphorylation of androgen receptors at serine 515 is a potential prognostic marker for triple negative breast cancer Integrated diagnostic network construction reveals a 4-gene panel and 5 cancer hallmarks driving breast cancer heterogeneity.The synthetic antihyperlipidemic drug potassium piperate selectively kills breast cancer cells through inhibiting G1-S-phase transition and inducing apoptosis.Copy Number Profiling of MammaPrint™ Genes Reveals Association with the Prognosis of Breast Cancer Patients.miR-19b promotes breast cancer metastasis through targeting MYLIP and its related cell adhesion molecules.RIFS: a randomly restarted incremental feature selection algorithm.TROVE: A User-friendly Tool for Visualizing and Analyzing Cancer Hallmarks in Signaling Networks.Computer-aided evaluation of the correlation between MRI morphology and immunohistochemical biomarkers or molecular subtypes in breast cancer.Breast Cancer Cell Line Classification and Its Relevance with Breast Tumor Subtyping.VEGF and TWIST1 in a 16-biomarker immunoprofile useful for prognosis of breast cancer patients.Fundamentals of siRNA and miRNA therapeutics and a review of targeted nanoparticle delivery systems in breast cancer.Preclinical study of a Kv11.1 potassium channel activator as antineoplastic approach for breast cancer.Targeting the Epigenome as a Novel Therapeutic Approach for Breast Cancer.High expression of endoglin in primary breast cancer may predict response to neoadjuvant chemotherapy.The Potential for Connexin Hemichannels to Drive Breast Cancer Progression through Regulation of the Inflammatory Response.ABC Transporters and Their Role in the Neoadjuvant Treatment of Esophageal Cancer.FOXD1 predicts prognosis of colorectal cancer patients and promotes colorectal cancer progression via the ERK 1/2 pathway.Identification of Biomarkers Based on Differentially Expressed Genes in Papillary Thyroid Carcinoma.

P2860

Q33736044-C652E375-9F36-4A62-818E-A8F1BA0337DA Q33788060-D7A91383-382B-45C7-9711-24EFB078377B Q33913872-BA5DE73C-80A8-4B4E-8107-9C2A8BA1B77F Q38430594-57D7E483-F2C9-4925-9411-FF4390A4AFC9 Q41471022-2A55C568-D5B8-4D3C-9373-568EB4320EB9 Q41843765-700C08BD-497A-4BF6-B05E-75B2303929C8 Q41984092-57299F34-3FD0-4666-96B1-7199D991BBC0 Q42376068-3C677A89-00FC-4D7A-9F65-5E4FE1936AEF Q42696201-7ADAD3E8-6686-42EB-9337-934A18AF057D Q47095927-BBC35F78-0CBD-49D4-BD7F-24270B99B617 Q47100468-972A601A-2C8E-4D50-9FE4-0A8D19C3B72C Q48177300-2A85E2BB-6022-4BA3-93B5-C0881E1B3C65 Q48256868-B9A53D05-B626-4F60-911A-9CA53C8F7F3A Q48505210-8FB686AC-6143-49EE-AA27-2FEBF47FC5F0 Q49544302-E4EDFB74-0B94-421E-BD20-94B63C1D0147 Q49852158-1C571409-03BB-488C-ACF4-81CB1FB2A25C Q53699942-27330B7D-2D75-405C-AEEE-CB1AD574080A Q55000594-0776AFF0-E661-4CCA-8C82-7BA94015677B Q55387120-B65B5EE5-6A49-442E-AEAC-D30F12BC1C81 Q55472371-62549E71-6322-4C46-B930-83C9CC6DA0F4

P2860

Cancer Hallmarks, Biomarkers and Breast Cancer Molecular Subtypes

http://www.wikidata.org/entity/Q26743510

description

2016 nî lūn-bûn

@nan

2016 թուականին հրատարակուած գիտական յօդուած

@hyw

2016 թվականին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

name

Cancer Hallmarks, Biomarkers and Breast Cancer Molecular Subtypes

@ast

Cancer Hallmarks, Biomarkers and Breast Cancer Molecular Subtypes

@en

Cancer Hallmarks, Biomarkers and Breast Cancer Molecular Subtypes

@nl

type

label

Cancer Hallmarks, Biomarkers and Breast Cancer Molecular Subtypes

@ast

Cancer Hallmarks, Biomarkers and Breast Cancer Molecular Subtypes

@en

Cancer Hallmarks, Biomarkers and Breast Cancer Molecular Subtypes

@nl

prefLabel

Cancer Hallmarks, Biomarkers and Breast Cancer Molecular Subtypes

@ast

Cancer Hallmarks, Biomarkers and Breast Cancer Molecular Subtypes

@en

Cancer Hallmarks, Biomarkers and Breast Cancer Molecular Subtypes

@nl

P1433

Q26743510-ECCA48FE-75E8-4ECA-B8D3-ED856CF3636A

P1476

Q26743510-85F8BD60-0DCE-467D-8E12-0B8E0D30AADD

P2093

Q26743510-025D563D-B926-402D-A018-107579B9257C

Q26743510-6540B47F-D603-4B38-864F-33AF68DCFD24

Q26743510-6CBE06AE-A191-4A53-9AAB-7BE00B7060F7

Q26743510-FDB9C47B-B6DE-496C-A61E-A75BFEB57CE1

P2860

Q26743510-00D05ED4-4EC9-4E6F-9844-39B77EFFC3BC

Q26743510-025A7E7F-6B3E-4597-BAD6-888AEC87153E

Q26743510-03462304-124F-45A2-9FAA-FB0D951E93CC

Q26743510-03C417CB-7034-45F3-A9DF-91384DB76F98

Q26743510-07DF8298-C3E6-42A5-98EC-2A45D52B524F

Q26743510-0DAEFF60-7D9F-4338-85CF-A40CBB16ACEF

Q26743510-0E16FDE8-856D-4AC0-B75E-47B56137BA0C

Q26743510-104C585E-9DE3-4C7F-A502-8854B614504A

Q26743510-115CFF23-CB11-4248-BAB6-EE440466F49D

Q26743510-118E36F7-B82B-47C3-9F3A-553C123EDCB6

P304

Q26743510-88DD7DB6-3250-4387-9452-ACCE9BDA86D4

P31

Q26743510-1110F282-878A-4887-BA3C-C654A5658DC3

P3181

Q26743510-0F96F5F5-C8EC-4BFD-B0F2-97A41539131B

P356

Q26743510-82291283-7F7F-45CA-86D8-0D70CCBC9D01

P407

Q26743510-0289C552-4CA2-432F-BAA6-6D7EE0C96F75

P433

Q26743510-4CB61CBC-3ADB-4AA2-A11E-67575CBBDE07

P478

Q26743510-2385C242-ED1A-4FA7-9B84-C114484C49E7

P577

Q26743510-35002813-32CF-4725-A2E6-E468ED390B7D

P698

Q26743510-4730D9CD-B544-40AA-9451-DB56AA17D432

P921

Q26743510-79DFB40C-E8E9-4C63-AA66-6F4C26F12EF8

P932

Q26743510-9E5F7489-A552-4EC7-A576-731A7CA33084

P3181

P356

P1433

Journal of Cancer

P1476

Cancer Hallmarks, Biomarkers and Breast Cancer Molecular Subtypes

@en

P2093

Liangjian Xiang

http://www.w3.org/2001/XMLSchema#string

Ting Li

http://www.w3.org/2001/XMLSchema#string

Xiaofeng Dai

http://www.w3.org/2001/XMLSchema#string

Zhonghu Bai

http://www.w3.org/2001/XMLSchema#string

P2860

The Hallmarks of Cancer

Hallmarks of Cancer: The Next Generation

Targeting androgen receptor in estrogen receptor-negative breast cancer

BCL2 in breast cancer: a favourable prognostic marker across molecular subtypes and independent of adjuvant therapy received

Comprehensive molecular portraits of human breast tumours

MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype

Association of GATA3, P53, Ki67 status and vascular peritumoral invasion are strongly prognostic in luminal breast cancer

Prognostic value of proliferation in invasive breast cancer: a review

Determination of stromal signatures in breast carcinoma.

Tamoxifen may prevent both ER+ and ER- breast cancers and select for ER- carcinogenesis: an alternative hypothesis.

P304

1281-94

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

548552

http://www.w3.org/2001/XMLSchema#string

P356

10.7150/JCA.13141

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2016-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27390604

http://www.w3.org/2001/XMLSchema#string

P921

P932

4934037

http://www.w3.org/2001/XMLSchema#string